The Massachusetts Cost Containment Bill: Implementation and Economic Impact
September 23, 2008
To obtain a legislative and regulatory perspective on The Massachusetts Cost Containment Bill, we invite you to attend a program sponsored by Foley & Lardner LLP and the Massachusetts Health Council, Inc. titled “The Massachusetts Cost Containment Bill: Implementation and Economic Impact.”
The program includes a welcome and brief remarks from:
-
Marylou Buyse, M.D., President, MA Health Council, President, MA Association of Health Plans
-
Alan Einhorn, Esq., Board of Directors, MA Health Council, Attorney, Foley & Lardner LLP
Presenters include:
-
Senator Richard Moore, Co-Chairman, Joint Committee on Health Care Financing
-
Secretary JudyAnn Bigby, M.D. (invited), Executive Office of Health and Human Services
-
Commissioner John Auerbach, MA Department of Public Health
To register, please send your name, organization name, address, phone number and e-mail address to mahealthcouncil@aol.com. Please list all those who plan to attend.
People
Related Insights
June 6, 2025
Energy Current
House Bill 3809 Adds Obligations to Battery Energy Storage Lessees in Texas
On May 29, 2025, House Bill No. 3809 was signed into law by Texas Governor Greg Abbott. Born out of a crop of bills regulating renewable…
June 23, 2025
Events
Third Annual Transaction Solutions Symposium
Foley & Lardner is sponsoring the Third Annual Transaction Solutions Symposium — a premier conference focused on de-risking strategies that enhance deal execution and business outcomes. Rishi Sodhi will be speaking as part of the Tax Liability Insurance: Current Trends, Controversies and Claims panel.
June 5, 2025
Health Care Law Today
GLP-1 Compounded Medications Targeted by Connecticut Attorney General
On May 21, 2025, the Connecticut Office of the Attorney General released a statement and sent letters to Connecticut weight loss clinics, med spas, medical practices and other businesses regarding allegedly or potentially unfair and deceptive conduct relating to compounded GLP-1 medications.